{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:31:46Z","timestamp":1758990706189,"version":"3.40.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY018659","EY019309","GM104934","GM122744"],"award-info":[{"award-number":["EY018659","EY019309","GM104934","GM122744"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"publisher","award":["2-SRA-2014-147-Q-R"],"award-info":[{"award-number":["2-SRA-2014-147-Q-R"]}],"id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008569","name":"Oklahoma Center for the Advancement of Science and Technology","doi-asserted-by":"publisher","award":["HR16-041"],"award-info":[{"award-number":["HR16-041"]}],"id":[{"id":"10.13039\/100008569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microvascular Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.mvr.2018.03.011","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T06:31:30Z","timestamp":1523082690000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Anti-angiogenic effect of a humanized antibody blocking the Wnt\/\u03b2-catenin signaling pathway"],"prefix":"10.1016","volume":"119","author":[{"given":"Fangfang","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Younghwa","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James W.","family":"Larrick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Mendelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8815-1716","authenticated-orcid":false,"given":"Jian-xing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mvr.2018.03.011_bb0005","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1189\/jlb.1107783","article-title":"C-Jun NH2 terminal kinase (JNK) is an essential mediator of toll-like receptor 2-induced corneal inflammation","volume":"83","author":"Adhikary","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"4","key":"10.1016\/j.mvr.2018.03.011_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3816\/SCT.2006.n.023","article-title":"Adverse effects of bevacizumab and their management in solid tumors","volume":"3","author":"Arriaga","year":"2006","journal-title":"Supportive Cancer Ther."},{"key":"10.1016\/j.mvr.2018.03.011_bb0015","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American ophthalmological society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"10 Suppl","key":"10.1016\/j.mvr.2018.03.011_bb0020","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.ophtha.2009.06.048","article-title":"Antiangiogenic approaches to age-related macular degeneration today","volume":"116","author":"Bressler","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.mvr.2018.03.011_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1749-6632.2000.tb06320.x","article-title":"Molecular basis of angiogenesis. Role of VEGF and VE-cadherin","volume":"902","author":"Carmeliet","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"5","key":"10.1016\/j.mvr.2018.03.011_bb0030","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2007-04-086231","article-title":"Activation of Epac stimulates integrin-dependent homing of progenitor cells","volume":"111","author":"Carmona","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mvr.2018.03.011_bb0035","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"issue":"3","key":"10.1016\/j.mvr.2018.03.011_bb0040","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3892\/mmr.2016.4869","article-title":"Wnt3a suppresses Pseudomonas aeruginosa-induced inflammation and promotes bacterial killing in macrophages","volume":"13","author":"Chen","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.011_bb0045","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.2353\/ajpath.2009.080945","article-title":"Activation of the Wnt pathway plays a pathogenic role in diabetic retinopathy in humans and animal models","volume":"175","author":"Chen","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mvr.2018.03.011_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.visres.2017.02.007","article-title":"Canonical Wnt signaling in diabetic retinopathy","volume":"139","author":"Chen","year":"2017","journal-title":"Vis. Res."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.011_bb0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1358\/dot.2005.41.1.875776","article-title":"Bevacizumab: antiangiogenic cancer therapy","volume":"41","author":"Culy","year":"2005","journal-title":"Drugs Today"},{"issue":"8","key":"10.1016\/j.mvr.2018.03.011_bb0060","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1161\/CIRCRESAHA.110.223750","article-title":"The role of wnt signaling in physiological and pathological angiogenesis","volume":"107","author":"Dejana","year":"2010","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.mvr.2018.03.011_bb0065","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.mvr.2018.03.011_bb0070","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd2115","article-title":"Angiogenesis: an organizing principle for drug discovery?","volume":"6","author":"Folkman","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.011_bb0075","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2174\/157339908783502361","article-title":"Role of inflammation in diabetic nephropathy","volume":"4","author":"Fornoni","year":"2008","journal-title":"Curr. Diabetes Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.mvr.2018.03.011_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000088481","article-title":"Managing patients treated with bevacizumab combination therapy","volume":"69","author":"Gordon","year":"2005","journal-title":"Oncology"},{"issue":"2","key":"10.1016\/j.mvr.2018.03.011_bb0085","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/ICU.0b013e3283360aad","article-title":"Anti-VEGF therapy for glaucoma","volume":"21","author":"Horsley","year":"2010","journal-title":"Curr. Opin. Ophthalmol."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.011_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jcma.2014.10.002","article-title":"Corneal neovascularization and contemporary antiangiogenic therapeutics","volume":"78","author":"Hsu","year":"2015","journal-title":"J. Chin. Med. Assoc."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.011_bb0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1167\/iovs.12-10281","article-title":"Pathogenic role of the Wnt signaling pathway activation in laser-induced choroidal neovascularization","volume":"54","author":"Hu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.mvr.2018.03.011_bb0100","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrc2389","article-title":"Wnt signalling and its impact on development and cancer","volume":"8","author":"Klaus","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"8","key":"10.1016\/j.mvr.2018.03.011_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081786","article-title":"A review of anti-angiogenic targets for monoclonal antibody cancer therapy","volume":"18","author":"Kong","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.mvr.2018.03.011_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000268009","article-title":"Combined non-steroidal therapy in experimental corneal injury","volume":"29","author":"Laria","year":"1997","journal-title":"Ophthalmic Res."},{"issue":"11","key":"10.1016\/j.mvr.2018.03.011_bb0115","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.2337\/db11-0300","article-title":"Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy","volume":"61","author":"Lee","year":"2012","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.mvr.2018.03.011_bb0120","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.mvr.2018.03.011_bb0125","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.exer.2006.11.014","article-title":"Establishment of a corneal epithelial cell line spontaneously derived from human limbal cells","volume":"84","author":"Liu","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.011_bb0130","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.intimp.2015.07.036","article-title":"Anti-TNF-alpha monoclonal antibody reverses psoriasis through dual inhibition of inflammation and angiogenesis","volume":"28","author":"Liu","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.mvr.2018.03.011_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1152\/physiol.00058.2005","article-title":"Wnt\/frizzled signaling in the vasculature: new angiogenic factors in sight","volume":"21","author":"Masckauchan","year":"2006","journal-title":"Physiology"},{"issue":"4","key":"10.1016\/j.mvr.2018.03.011_bb0140","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11882-008-0054-2","article-title":"Biologic agents in the management of inflammatory eye diseases","volume":"8","author":"Michalova","year":"2008","journal-title":"Curr Allergy Asthma Rep"},{"issue":"5","key":"10.1016\/j.mvr.2018.03.011_bb0145","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1182\/blood.V62.5.988.988","article-title":"Monoclonal antibody therapeutic trials in seven patients with T-cell lymphoma","volume":"62","author":"Miller","year":"1983","journal-title":"Blood"},{"issue":"5573","key":"10.1016\/j.mvr.2018.03.011_bb0150","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1126\/science.1071549","article-title":"The promise and perils of Wnt signaling through beta-catenin","volume":"296","author":"Moon","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.mvr.2018.03.011_bb0155","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1681\/ASN.2007091048","article-title":"The role of inflammatory cytokines in diabetic nephropathy","volume":"19","author":"Navarro-Gonzalez","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.mvr.2018.03.011_bb0160","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.yexcr.2005.11.008","article-title":"VEGF function in vascular pathogenesis","volume":"312","author":"Ng","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.011_bb0165","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/biof.1185","article-title":"Green tea polyphenol EGCG suppresses Wnt\/beta-catenin signaling by promoting GSK-3beta- and PP2A-independent beta-catenin phosphorylation\/degradation","volume":"40","author":"Oh","year":"2014","journal-title":"Biofactors"},{"key":"10.1016\/j.mvr.2018.03.011_bb0170","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.fct.2016.04.019","article-title":"Cytotoxic activity of aeroplysinin-1 against colon cancer cells by promoting beta-catenin degradation","volume":"93","author":"Park","year":"2016","journal-title":"Food Chem. Toxicol."},{"issue":"8","key":"10.1016\/j.mvr.2018.03.011_bb0175","first-page":"2449","article-title":"Leukocyte adhesion molecules in diseased corneas","volume":"34","author":"Philipp","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.011_bb0180","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.20132330","article-title":"Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells","volume":"211","author":"Raimondi","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mvr.2018.03.011_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.exer.2014.09.011","article-title":"HCV core and NS3 proteins mediate toll like receptor induced innate immune response in corneal epithelium","volume":"128","author":"Rajalakshmy","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"7","key":"10.1016\/j.mvr.2018.03.011_bb0190","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/21505594.2015.1066063","article-title":"Recognition of Corynebacterium pseudodiphtheriticum by toll-like receptors and up-regulation of antimicrobial peptides in human corneal epithelial cells","volume":"6","author":"Roy","year":"2015","journal-title":"Virulence"},{"issue":"10","key":"10.1016\/j.mvr.2018.03.011_bb0195","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1167\/iovs.08-2669","article-title":"Release of soluble tumor necrosis factor receptor 1 from corneal epithelium by TNF-alpha-converting enzyme-dependent ectodomain shedding","volume":"50","author":"Sakimoto","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.mvr.2018.03.011_bb0200","first-page":"879","article-title":"Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapy","volume":"45","author":"Schroff","year":"1985","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.mvr.2018.03.011_bb0205","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1517\/14728222.2014.906580","article-title":"The potential of targeting Wnt\/beta-catenin in colon cancer","volume":"18","author":"Sebio","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"10","key":"10.1016\/j.mvr.2018.03.011_bb0210","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-2443.1998.00221.x","article-title":"Cytoskeletal reorganization by soluble Wnt-3a protein signalling","volume":"3","author":"Shibamoto","year":"1998","journal-title":"Genes Cells"},{"issue":"1","key":"10.1016\/j.mvr.2018.03.011_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2013.113","article-title":"VEGF-VEGFR signals in health and disease","volume":"22","author":"Shibuya","year":"2014","journal-title":"Biomol. Ther."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.011_bb0220","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy","volume":"2","author":"Simo","year":"2006","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.mvr.2018.03.011_bb0225","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biocel.2015.09.008","article-title":"Multi-lineage differentiation of mesenchymal stem cells - to Wnt, or not Wnt","volume":"68","author":"Visweswaran","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.mvr.2018.03.011_bb0230","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/ATVBAHA.114.304627","article-title":"Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization","volume":"35","author":"Wang","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.mvr.2018.03.011_bb0235","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/ICO.0000000000000032","article-title":"Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V","volume":"33","author":"Wang","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.mvr.2018.03.011_bb0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40035-015-0033-1","article-title":"Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function","volume":"4","author":"Wei","year":"2015","journal-title":"Transl. Neurodegener."},{"issue":"1","key":"10.1016\/j.mvr.2018.03.011_bb0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10456-008-9095-3","article-title":"Wnt\/frizzled signaling in angiogenesis","volume":"11","author":"Zerlin","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.mvr.2018.03.011_bb0250","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.exer.2015.02.013","article-title":"Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients","volume":"134","author":"Zheng","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.mvr.2018.03.011_bb0255","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1167\/iovs.14-14023","article-title":"Serine proteinase inhibitor SERPINA3K suppresses corneal neovascularization via inhibiting Wnt signaling and VEGF","volume":"55","author":"Zhou","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"9","key":"10.1016\/j.mvr.2018.03.011_bb0260","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1167\/iovs.09-4278","article-title":"The pathogenic role of the canonical Wnt pathway in age-related macular degeneration","volume":"51","author":"Zhou","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Microvascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286217302236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026286217302236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T14:45:21Z","timestamp":1660833921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026286217302236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":52,"alternative-id":["S0026286217302236"],"URL":"https:\/\/doi.org\/10.1016\/j.mvr.2018.03.011","relation":{},"ISSN":["0026-2862"],"issn-type":[{"type":"print","value":"0026-2862"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-angiogenic effect of a humanized antibody blocking the Wnt\/\u03b2-catenin signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Microvascular Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mvr.2018.03.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}